Here are the top 4 Clinical Trials unicorns as of January 2024:
1. Reify Health
Description: Reify Health develops cloud-based software tools for the clinical trial ecosystem.
Valuation: $4.80B (August 2021)
Country: United States
State: Massachusetts
City: Boston
Founded: 2012
Founders: Henry Li, Joseph Abrahamson, Michael Lin, Pramod Verma, Ralph Passarella
Employees: 100-250
Funding: $257.64M
Funding Rounds: 6
Number of Investors: 8
2. Alzheon
Description: Alzheon focuses on developing therapies for brain function, memory, and aging.
Valuation: $1.31B (September 2020)
Country: United States
State: Massachusetts
City: Framingham
Founded: 2013
Founder: Martin Tolar
Employees: 10-50
Funding: $94.40M
Funding Rounds: 7
Number of Investors: 3
3. TrialSpark
Description: TrialSpark aims to accelerate clinical trials by innovating trial management technology.
Valuation: $1.00B (September 2021)
Country: United States
State: New York
City: New York
Founded: 2014
Founders: Benjamine Liu, Kit Dobyns, Linhao Zhang
Employees: 100-250
Funding: $238.30M
Funding Rounds: 3
Number of Investors: 13
4. Owkin
Description: Owkin uses artificial intelligence to optimize treatment decisions through data analysis.
Valuation: $1.00B (November 2021)
Country: United States
State: New York
City: New York
Founded: 2016
Founders: Gilles Wainrib, Thomas Clozel
Employees: 100-250
Funding: $254.10M
Funding Rounds: 7
Number of Investors: 15
These companies are leveraging advanced technologies and innovative approaches to improve the efficiency and effectiveness of clinical trials, addressing critical healthcare challenges through their pioneering work.